ACASUNLIMAB

UNII:	H52ITZ9X9D
Formula:
Preferred Substance Name:	ACASUNLIMAB
GSRS Full Record:	H52ITZ9X9D i

2253937-12-9
ACASUNLIMAB [INN]
ACASUNLIMAB [WHO-DD]
GEN1046
GEN-1046
HUMAN IGG1 LAMBDA ANTI CD274 DIMER AND HUMANISED IGG1 KAPPA ANTI CD137 BISPECIFIC ANTIBODY GEN1046-DS
IMMUNOGLOBULIN G1 (238-PHENYLALANINE,239-GLUTAMIC ACID,269-ALANINE,409-LEUCINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL IGG1-7717-547-FEAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IGG1-7717-547-FEAL .LAMBDA.-CHAIN, DIMER WITH IMMUNOGLOBULIN G1 (234-PHENYLALANINE,235-GLUTAMIC ACID,265-ALANINE,409-ARGININE), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR TNFRSF9) (HUMAN MONOCLONAL IGG1-CD137-009-HC7LC2-FEAR .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IGG1-CD137-009-HC7LC2-FEAR .KAPPA.-CHAIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ACASUNLIMAB

Synonyms and Mappings

Resources